Real‐life data of luspatercept in lower‐risk myelodysplastic syndromes advocate new research objectives.

Authors: Heyrman, Bert, Meers, Stef, Sid, Sélim, Put, Natalie, Theunissen, Koen, Van Eygen, Koen, De Beule, Nathan, Clauwaert, Maxime, Maes, Helena, Salembier, Alexander, Lemmens, Jan, Velde, Ann Van De, Selleslag, Dominik, Bouziotis, Jason, De Becker, Ann, Anguille, Sébastien

Source: EJHaem; Oct2024, Vol. 5 Issue 5, p1096-1099, 4p